| abstract |
The present disclosure provides an isolated binding molecule that binds to human 4-1BB, a nucleic acid molecule encoding the amino acid sequence of the binding molecule, a vector comprising the nucleic acid molecule, a host cell comprising the vector, and a method of making the same A pharmaceutical composition comprising the binding molecule, and a method of using the binding molecule or composition. |